Abstract
The aim of the present study was to compare the effects of the typical antipsychotic haloperidol and the atypical antipsychotics clozapine and olanzapine on both extracellular dopamine (DA) levels in the medial prefrontal cortex (mPFC) as well as electrical activity of mesoprefrontal DA (mPFC-DA) neurons. Extracellular single unit recordings and microdialysis experiments were carried out in different groups of chloral hydrate anesthetised rats under identical experimental conditions. Intravenous administration of haloperidol, clozapine, and olanzapine increased the firing rate and burst activity of antidromically-identified mPFC-DA neurons; maximal increase in firing rate of approximately 140, 155, and 70 %, was produced by haloperidol, clozapine, and olanzapine at doses of 0.2, 2.5, and 1 mg/kg, i.v., respectively. Intravenous administration of the same doses increased extracellular DA levels in mPFC by 20%, 190%, and 70%, respectively. Moreover, while haloperidol and olanzapine increased extracellular levels of the deaminated DA metabolite DOPAC, by 60% and 40%, respectively, clozapine was totally ineffective. The D1 receptor antagonist SCH 23390 modified neither DA output nor neuronal firing. To determine whether the effect of the three antipsychotics on DA release might depend on a direct action on the mPFC, rats were perfused locally via inverse dialysis in the mPFC at concentrations ranging from 10−6 to 10−4M. While clozapine and olanzapine increased extracellular DA concentrations by up to 400% of basal level, haloperidol was totally ineffective. The results obtained from this study indicate that the rank potency of the three antipsychotics in stimulating the firing rate of DA neurons projecting to mPFC, correlates with their affinity for D2 receptors and doses used clinically. On the other hand, their stimulating effect on DA release does not correlate with their effect on neuronal firing but depends on a direct action on the mPFC.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Brunello N, Masotto C, Steardo L, Markstein R, Racagni G . (1995): New insight into the biology of schizophrenia through the mechanism of action of clozapine. Neuropsychopharmacology 13: 177–213
Bunney BS, Walters JR, Roth RH, Aghajanian GK . (1973): Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. Pharmacol Exp Ther 185: 560–571
Bymaster F, Perry KW, Nelson DL, Wong DT, Rasmussen K, Moore NA, Calligaro DO . (1999): Olanzapine: A basic science update. Br J Psychiatry 174 (37): S36–S40
Chiodo LA, Bunney BS . (1983): Typical and atypical neuroleptics: Differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J Neurosci 3: 1607–1619
Creese I, Burt DR, Snyder SH . (1976): Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192: 481–483
Daniel DG, Weinberger DR, Jones DW . (1991): The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia. J Neurosci 11: 1907–1917
Deutch AY . (1992): The regulation of subcortical dopamine systems by the prefrontal cortex: Interactions of central dopamine systems and the pathogenesis of schizophrenia. J Neural Transm 36: 61–89
Diana M, Garcia-Munoz M, Richards J, Freed CR . (1989): Electrophysiological analysis of dopamine cells from the substantia nigra pars compacta of circling rats. Exp Brain Res 74: 625–630
Fadda F, Gessa GL, Marcou M, Mosca E, Rossetti ZL . (1984): Evidence for dopamine autoreceptors in mesocortical dopamine neurons. Brain Res 283: 67–72
Gariano RF, Groves PM . (1988): Burst firing induced in midbrain dopamine neurons by stimulation of the medial prefrontal and anterior cingulate cortices. Brain Res 462: 194–198
Gariano RF, Tepper JM, Sawyer SF, Young SJ, Groves PM . (1989): Mesocortical dopamine neurons. I. Electrophysiological properties and evidence for soma-dendritic autoreceptors. Brain Res Bull 22: 511–516
Grace AA, Bunney BS . (1983): Intracellular and extracellular electrophysiology of nigral dopaminergic neurons. I. Identification and characterization. Neuroscience 10: 301–315
Grace AA, Bunney BS . (1984): The control of firing pattern in nigral dopamine neurons: Burst firing. J Neurosci 4: 2877–2890
Hand TH, Xiu-Ti H, Wang RY . (1987): Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons. Brain Res 415: 257–269
Kuroki T, Meltzer HY, Ichikawa J . (1999): Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens. J Pharmacol Exp Ther 288: 774–781
Lee S-HL, Oh D-Y, Jung S-C, Kim Y-M, Cho H-K, Koh J-K, Lee Y-S . (1997): Neuroleptic drugs alter the dopamine transporter-mediated uptake and release of dopamine: A possible mechanism for drug-induced tardive dyskinesia. Pharmacol Res 35: 447–450
Li X-M, Perry KW, Wong DT, Bymaster FP . (1998): Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum. Psychopharmacology 136: 153–161
Lidow MS, Williams GV, Goldman-Rakic PS . (1998): The cerebral cortex: A case for a common site of action of antipsychotics. Trends Pharmacol Sci 19 (4): 136–140
Lipski J . (1981): Antidromic activation of neurones as an analytic tool in the study of the central nervous system. J Neurosci Methods 4 (1): 1–32
Melis M, Diana M, Gessa GL . (1999): Clozapine potently stimulates mesocortical dopamine neurons. Eur J Pharmacol 366: R11–R13
Meltzer HY, Stahl SM . (1976): The dopamine hypothesis of schizophrenia: A review. Schizophr Bull 2: 19–76
Moghaddam B, Bunney BS . (1990): Acute effect of typical and atypical antipsychotic drugs on the release of dopamine from the prefrontal cortex, nucleus accumbens, and striatum of the rat: An in vivo microdialysis study. J Neurochem 54: 1755–1760
Nomikos GG, Iurlo M, Andersson JL, Kimura K, Svensson TH . (1994): Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex. Psychopharmacology 115: 147–156
Oades RD, Halliday GM . (1987): Ventral tegmental (A10) system: neurobiology. I. Anatomy and connectivity. Brain Res Rev 12: 117–165
Paxinos G, Watson C . (1986): The rat brain in stereotaxic coordinates. New York, Academic Press
Pehek EA, Yamamoto BK . (1994): Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen. J Neurochem 63: 2118–2124
Pehek EA . (1996): Local infusion of the serotonin antagonist ritanserin or ICS 205,930 increases in vivo dopamine release in the rat prefrontal cortex. Synapse 24 (1): 12–18
Pucak ML, Grace AA . (1994): Evidence that systemically administered dopamine antagonists activate dopamine neuron firing primarily by blockade of somatodendritic autoreceptors. J Pharmacol Exp Ther 271 (3): 1181–1192
Rollema H, Lu Y, Schmidt AW, Zorn SH . (1997): Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation. Eur J Pharmacol 338 (2): R3–R5
Sawaguchi T, Goldman-Rakic PS . (1991): D1 dopamine receptors in the prefrontal cortex. Involvement in working memory. Science 251: 947–950
Scatton B, Dennis T, Curet O . (1984): Increase in dopamine and DOPAC levels in noradrenergic terminals after electrical stimulation of the ascending noradrenergic pathways. Brain Res 298: 193–196
Schmidt CJ, Fedayel GM . (1995): The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat. Eur J Pharmacol 273 (3): 273–279
Seeman P, Lee T, Chau-Wong M, Wong K . (1976): Antipsychotic drug doses and neuroleptic/ dopamine receptors. Nature 261: 717–719
Snyder SH . (1976): The dopamine hypothesis of schizophrenia: Focus on the dopamine receptor. Am J Psychiatry 1 33 (2): 197–202
Stockton ME, Rasmussen K . (1996): Electrophysiological effects of olanzapine, a novel atypical antipsychotic, on A9 and A10 dopamine neurons. Neuropsychopharmacology 14 (2): 97–104
Volontè M, Monferini E, Cerutti M, Fodritto F, Borsini . (1997): BIMG 80, a novel potential antipsychotic drug: Evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex. J Neurochem 69: 182–190
Weinberger DR . (1987): Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44: 660–669
White FJ, Wang RY . (1983): Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science 221: 1054–1057
Wolf MR, Roth RH . (1987): Dopamine neurons projecting to the medial prefrontal cortex possess release-modulating autoreceptors. Neuropharmacology 26: 1053–1059
Acknowledgements
The authors thank Mr. Stefano Aramo for his skilled technical assistance and the company Ely Lilly for the gift of olanzapine.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gessa, G., Devoto, P., Diana, M. et al. Dissociation of Haloperidol, Clozapine, and Olanzapine Effects on Electrical Activity of Mesocortical Dopamine Neurons and Dopamine Release in the Prefrontal Cortex. Neuropsychopharmacol 22, 642–649 (2000). https://doi.org/10.1016/S0893-133X(00)00087-7
Received:
Revised:
Accepted:
Issue date:
DOI: https://doi.org/10.1016/S0893-133X(00)00087-7
Keywords
This article is cited by
-
A neuroimaging study of emotion–cognition interaction in schizophrenia: the effect of ziprasidone treatment
Psychopharmacology (2017)
-
A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight
Molecular Psychiatry (2013)
-
Clozapine increases reward evaluation but not overall ingestive behaviour in rats licking for sucrose
Psychopharmacology (2011)
-
Treatment with Olanzapine is Associated with Modulation of the Default Mode Network in Patients with Schizophrenia
Neuropsychopharmacology (2010)
-
Regional Differences in the Action of Antipsychotic Drugs: Implications for Cognitive Effects in Schizophrenic Patients
Neurotoxicity Research (2010)
